All you need to know about managing hepatitis C virus infection in Australia

What’s new in the 2022 Consensus Statement?

  • Update to the recommended definition of chronic hepatitis C
  • Update to the recommendations for screening and diagnosis of hepatitis C
  • Update to the recommended indications for treatment for hepatitis C infection
  • Label updates: glecaprevir plus pibrentasvir
  • Label updates: sofosbuvir plus velpatasvir
  • Simplified testing pathway to confirm cure
  • Use of non-invasive tools to screen for complications of portal hypertension in people living with cirrhosis
  • Updates on treatment of hepatitis C in people with HCC
  • Recommendations for managing dose interruptions in people receiving DAA therapy 
Read More

BROWSE TOPICS

Epidemiology and Models of Care

Screening and diagnosis

Pre-treatment assessment

Treatment for chronic hepatitis C

On-treatment monitoring

Post-treatment follow-up

Treating special populations

Decompensated liver disease
After liver transplantation
HIV coinfection
HBV coinfection
Renal impairment
Acute HCV infection

DAA therapy & risk of HCC in people with cirrhosis

CONTRIBUTORS